KardiaPro

by AliveCor  · Based in United States →Your Partner in Efficient Patient Monitoring and Analysis
Cardiology Family Medicine Internal Medicine

Contact for pricing
Regulatory Status Disclosed

Overview

KardiaPro is a comprehensive web-based portal designed for healthcare professionals to remotely monitor patient ECG, blood pressure, and weight data. It provides a secure platform to manage and review patient data between appointments, making it easier to analyze trends and make informed clinical decisions. The platform integrates seamlessly with AliveCor’s FDA-cleared Kardia™ devices, such as KardiaMobile and KardiaMobile 6L, centralizing patient data for clinical review and trend analysis. KardiaPro enhances clinical efficiency by enabling providers to receive, triage, and interpret cardiac recordings outside of traditional in-office settings, while maintaining regulatory compliance and supporting reimbursements under applicable CPT® codes. It helps clinicians detect arrhythmias, track longitudinal cardiac patterns, and manage large volumes of remote patient data securely from any internet-enabled workstation.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Comprehensive web-based portal for remote monitoring
  • ECG, blood pressure, and weight data management
  • FDA-cleared AI for arrhythmia detection
  • Customizable ECG inbox for efficient data review
  • Automated summary reports and trend visualization
  • Seamless integration with KardiaMobile and KardiaMobile 6L devices
  • Integration with KardiaStation for point-of-care solutions
  • HIPAA-compliant and SOC-2 certified data handling
  • Reimbursable using existing CPTu00ae codes
  • QT measurement capability (with 6-lead device)

Use Cases

  • Remote monitoring of cardiac patients
  • Early detection of arrhythmias like atrial fibrillation
  • Tracking longitudinal cardiac patterns
  • Managing chronic cardiovascular diseases
  • Streamlining in-office and remote patient data management
  • Supporting clinical decisions with real-time patient data

What Physicians Need to Know

ECG/EKG Analysis Capability
KardiaPro is a web-based portal for remote monitoring and analysis of ECG data captured by AliveCor's FDA-cleared KardiaMobile devices (single-lead and 6-lead). It provides instant analysis for detecting various arrhythmias and normal sinus rhythm. The platform allows customization of the ECG inbox to prioritize abnormal recordings and generates summary reports for trend identification. KardiaMobile 6L can also measure QT intervals and calculate QTc.
Arrhythmia Detection Accuracy
Kardia's AI algorithms, including 'Advanced Determinations,' are FDA-cleared and clinically validated for detecting Atrial Fibrillation (AFib), Bradycardia, Tachycardia, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Supraventricular Ectopy (SVE), and Sinus Rhythm with Wide QRS. Studies have shown high sensitivity (95.3-100%) and specificity (94-98.7%) for AF detection compared to expert cardiology over-read of 12-lead EKGs.
Heart Failure Risk Prediction
While KardiaPro primarily focuses on arrhythmia detection and ECG monitoring, AliveCor (the company behind KardiaPro) is involved in transforming cardiology through AI-driven insights. General AI predictive modeling for CVD risk can combine medical history, demographics, labs, imaging, and lifestyle data to deliver actionable cardiovascular risk predictions and intervention planning. Risk prediction models for heart failure exist, utilizing various clinical factors.
Cardiac Monitoring Integration
KardiaPro integrates seamlessly with AliveCor's KardiaMobile (single-lead and 6-lead) and KardiaMobile Card devices for remote patient monitoring. It also functions as a point-of-care solution when paired with KardiaStation. The platform supports EHR/third-party interoperability through SDK/API configurations, allowing for the automatic pulling of ECGs into EHR systems like Epic, Cerner, and athenahealth. KardiaPro can also integrate data from Omron blood pressure devices and Apple Health.
Real-Time Alert Capability
KardiaPro allows physicians to access patient ECG recordings immediately after they are captured. The customizable ECG inbox can prioritize abnormal recordings, enabling clinicians to quickly review and act on urgent cardiac data. Real-time analysis and alerts are provided for KardiaMobile 6L when prescribed and used with a connected smartphone.
Physician Tip

Leverage KardiaPro's customizable ECG inbox to efficiently triage and review abnormal recordings, focusing your attention where it's most needed. Utilize the summary reports and trend visualizations for longitudinal patient reviews and informed clinical decision-making. Encourage patients to consistently use their KardiaMobile devices for comprehensive remote monitoring, which can significantly reduce the need for in-office ECGs and traditional long-term monitors, especially for AFib management. The QT measurement capability with KardiaMobile 6L can be valuable for managing patients on QT-prolonging medications.

KardiaPro offers robust integration capabilities through its API and SDK, facilitating seamless data flow with Electronic Health Record (EHR) systems such as Epic, Cerner, and athenahealth. This allows for automated transfer of patient ECG, blood pressure, and weight data, streamlining workflows and supporting reimbursable billing under existing CPT codes. The platform also integrates with Omron blood pressure devices and Apple Health for a more comprehensive patient data overview.

Details

Category Cardiology AI, Clinical Decision Support & Reference, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing Contact AliveCor for pricing information; Reimbursable using existing CPT® codes
DeploymentCloud-hosted, Web-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

KardiaPro integrates with AliveCor's FDA-cleared Kardia devices, which include AI for detecting arrhythmias such as atrial fibrillation, bradycardia, and tachycardia. AliveCor received FDA clearance for KardiaMobile in 2012 for detecting atrial fibrillation and normal sinus rhythm.

Integrations
EHR Not specified
Specialties Cardiology, Family Medicine, Internal Medicine

What the Web Says

KardiaPro is a remote patient monitoring software that allows healthcare providers to track patients' vital signs and health conditions, particularly ECG, blood pressure, and weight data. It aims to improve chronic disease management, reduce in-person visits, and enhance patient care through continuous monitoring. The platform integrates with AliveCor's FDA-cleared Kardia devices, centralizing data for clinical review and trend analysis. Physicians have found it revolutionary for managing conditions like atrial fibrillation (AFib).

Overall: Positive

Strengths

  • Enables remote tracking of vital signs and health conditions, including ECG, blood pressure, and weight data.
  • Revolutionized the management of atrial fibrillation for some cardiologists, reducing the need for long-term monitors and in-office ECGs.
  • Provides a comprehensive dashboard for viewing patient health trends, allowing early identification of issues and treatment plan adjustments.
  • Facilitates patient engagement through features like medication and appointment reminders.
  • HIPAA compliant and SOC-2 certified, ensuring secure patient data management.
  • Supports reimbursable billing under existing remote monitoring CPTu00ae codes.

Limitations

  • Some patients may balk at the monthly charge for KardiaPro, as it's not always covered by insurance or Medicare.
  • The accuracy of computer diagnosis for less common rhythms can be inaccurate, even with advanced AI in the app.
  • The device is primarily for spot-checking and not continuous monitoring like a Holter monitor.
  • Some users have experienced issues with phone compatibility with the Kardia devices and app.
  • The app can be perceived as a 'paywall with a heartbeat' for certain features, requiring a subscription for full functionality.

Based on reviews from: SoftwareWorld, The Skeptical Cardiologist, Reddit, Digital Health, Kardia

Last updated: 2026-06-23

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate KardiaPro

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

AliveCor
AliveCor Launches AI-Powered Kardia 12L in Europe: The World's First Handheld 12-Lead ECG with a Unique Single-Cable Design
AliveCor received CE Mark for its Kardia 12L ECG System, an AI-powered, portable 12-lead ECG system with a single-cable design, and is launching it in Europe. This device is intended for healthcare professionals and can detect 35 cardiac determinations, aiming to improve patient and clinician experience with faster acquisition times.
2026-04
AI Business
AliveCor brings pocket-sized Kardia 12L ECG system with AI diagnostics to Europe
AliveCor has launched its Kardia 12L ECG system in Europe after receiving CE Mark approval, bringing its pocket-sized 12-lead ECG device with AI diagnostics to several European countries. The system, which has already seen significant adoption in the US, reduces ECG acquisition time by nearly 30% and helps identify cardiac events like myocardial infarction and ischemia.
2026-05
AliveCor
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
AliveCor received FDA clearance for five additional cardiac determinations for its KAI 12L AI, powering the Kardia 12L ECG System, bringing the total to 39 cleared determinations. This expansion enhances the diagnostic capabilities of the handheld 12-lead ECG system, which has seen growing adoption in the US and other regions since its launch in June 2024.
2026-01
PMC (JMIR Cardio)
Wearable Electrocardiogram Technology: Help or Hindrance to the Modern Doctor?
This peer-reviewed article discusses the role of wearable ECG technology, including KardiaPro, in modern medical practice, particularly for screening and detection of Atrial Fibrillation (AF). It highlights the potential benefits of these devices in patient involvement and rapid health monitoring, while also acknowledging the challenges of integrating them into existing healthcare workflows.
2025-02
Medical Device Network
TLV recommends AliveCor KardiaMobile and KardiaPro for AF treatment
The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has recommended AliveCor's KardiaMobile and KardiaPro as a cost-effective option for detecting atrial fibrillation (AF). The assessment compared the combination to Holter ECG, finding it suitable for remote monitoring of patients, particularly those post-surgery or on frequency-regulating medication for AF.
2022-02
PR Newswire
AliveCor Lists its Industry-leading KardiaMobile 6L in Epic's App Orchard Marketplace
AliveCor announced that its KardiaMobile 6L, a six-lead personal ECG device, is available via KardiaPro on Epic's App Orchard Marketplace. This integration aims to provide healthcare providers with seamless access to remote ECG monitoring solutions for patients with electronic health records at Epic-using hospitals.
2021-12
AI-Tech Park
PaceMate Announces First-in-Market Collaboration with AliveCor
PaceMate announced a collaboration with AliveCor to integrate AliveCor's KardiaPro platform with PaceMateLIVE, combining their cardiac remote monitoring strengths. This partnership aims to provide healthcare providers with comprehensive access to ECG data and actionable reports for at-risk patients, streamlining workflows and improving patient care.
2023-05
JMIR Cardio
Outcomes of a Remote Cardiac Rehabilitation Program for Patients Undergoing Atrial Fibrillation Ablation: Pilot Study
This pilot study investigated the outcomes of a remote cardiac rehabilitation program for patients undergoing atrial fibrillation ablation, utilizing KardiaMobile 6L devices and the KardiaPro platform for ECG review and storage. The study demonstrated high adherence rates for daily blood pressure and ECG recordings and reported no program-related adverse events.
2023-12

Videos

Product demos, reviews, and walkthroughs for KardiaPro.

Loading videos...

View all on YouTube

Frequently Asked Questions

KardiaPro leverages AI to analyze ECGs for potential arrhythmias, providing automated interpretations and flagging studies that may require further review. This AI-powered analysis aims to enhance the efficiency of ECG interpretation and support earlier detection of cardiac events.
KardiaPro is FDA-cleared, and AliveCor, its developer, adheres to HIPAA regulations for patient data privacy and security. The platform is designed to ensure the secure handling and transmission of sensitive patient information.
KardiaPro differentiates itself through its integration with KardiaMobile devices for personal ECG recording, its AI-driven interpretive algorithms, and its physician-facing platform for streamlined review and practice management. While other solutions exist, KardiaPro focuses on ease of use for both patients and providers, alongside its AI capabilities.
KardiaPro typically operates on a subscription model, with pricing that can vary based on the number of patients monitored and the specific features required by a practice. It's best to contact AliveCor directly for detailed pricing information tailored to your practice's needs.
While KardiaPro's AI is highly effective in detecting common arrhythmias like atrial fibrillation, it has limitations in diagnosing all cardiac conditions. Physicians should always use their clinical judgment and consider the patient's full medical history when interpreting KardiaPro's findings, especially in complex cases or specific patient populations where AI accuracy might vary.
KardiaPro offers integration capabilities with various EHR systems, allowing for the seamless transfer of ECG data and interpretations into patient charts. The specific integration process and workflow can vary depending on your EHR system, and AliveCor provides support for setting up these connections.
AliveCor provides comprehensive training and support for KardiaPro users, including educational resources, online tutorials, and direct customer support. This ensures that physicians and their staff can effectively utilize the platform and confidently interpret its AI-driven insights.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

More from AliveCor

AliveCor QT Service
AliveCor
Cardiology AI
A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions.
Corvair
AliveCor
Cardiology AI
Corvair by AliveCor is an FDA-cleared AI ECG analysis system that assists healthcare professionals in interpreting resting diagnostic ECGs with 35 cardiac determinations.
Impala
AliveCor
Cardiology AI
AliveCor's 'Impala' (FDA K232035) is a portable, AI-powered 12-Lead ECG device for healthcare professionals, not a physician directory tool. AliveCor specializes in cardiac monitoring solutions.
Kardia 12L and KAI 12L
AliveCor
Cardiology AI
Kardia 12L and KAI 12L offer a portable, AI-powered 12-lead ECG system for healthcare professionals, enabling rapid and accurate detection of numerous cardiac conditions with a simplified setup.

View company profile →

Suggest an Edit → | Last Verified: 2026-06-23 | First Added: 2026-06-23

Investors who backed KardiaPro

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.